Entrada Therapeutics (TRDA) Net Margin (2023 - 2026)
Entrada Therapeutics' (TRDA) quarterly Net Margin came in at 4539.09% in Q1 2026, down 445470.0% year-on-year from N/an in Q1 2025, and down 50.52% quarter-over-quarter from 3015.55% in Q4 2025.
Entrada Therapeutics (TRDA) Net Margin (2023 - 2026) Analysis & Trends
Entrada Therapeutics' Net Margin history runs 4 years deep, the most recent figure standing at 4539.09% for Q1 2026.
- On a quarterly basis, Net Margin fell 445470.0% year-over-year to 4539.09% in Q1 2026; TTM through Mar 2026 was 2895.57%, a 290994.0% decrease from a year earlier, with the FY2025 full-year figure at 565.38%, down 59652.0% from the prior year.
- Net Margin eased to 4539.09% in Q1 2026 per TRDA's latest filing, from 3015.55% in the prior quarter.
- Across five years, Net Margin topped out at 81.09% in Q3 2023 and bottomed at 4539.09% in Q1 2026.
- The 4-year median for Net Margin is 71.7% (2024), against an average of 974.36%.
- Across the five-year window, Net Margin surged 20077 bps in 2024 and sank 445470 bps in 2026, its largest moves.
- Year by year, Net Margin stood at 22.71% in 2023, then jumped by 113 bps to 3.02% in 2024, then plunged by 99813 bps to 3015.55% in 2025, then plunged by 51 bps to 4539.09% in 2026.
- Per Business Quant, the three latest TRDA Net Margin figures stand at 4539.09% (Q1 2026), 3015.55% (Q4 2025), and 2734.45% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Entrada Therapeutics | 253.11 Mn | 253.11 Mn | - | -4,539.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,539.09% |
| Dec 31, 2025 | -3,015.55% |
| Sep 30, 2025 | -2,734.45% |
| Jun 30, 2025 | -2,211.54% |
| Mar 31, 2025 | -84.39% |
| Dec 31, 2024 | 3.02% |
| Sep 30, 2024 | -71.70% |
| Jun 30, 2024 | 58.07% |
| Mar 31, 2024 | 39.74% |
| Dec 31, 2023 | -22.71% |
| Sep 30, 2023 | 81.09% |
| Jun 30, 2023 | -142.70% |
| Mar 31, 2023 | -26.42% |